|
|
Volumn 4, Issue SUPPL. 1, 2003, Pages
|
|
Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties
|
|
Author keywords
Indications; Triptans
|
|
Indexed keywords
ALMOTRIPTAN;
ANTIMIGRAINE AGENT;
NARATRIPTAN;
RIZATRIPTAN;
SUMATRIPTAN;
ZOLMITRIPTAN;
ARTICLE;
CANADA;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG SAFETY;
EUROPE;
FRANCE;
GERMANY;
HUMAN;
IRELAND;
ITALY;
LICENSING;
MIGRAINE;
PRIORITY JOURNAL;
SUPPOSITORY;
SWEDEN;
TABLET FORMULATION;
UNITED KINGDOM;
UNITED STATES;
|
|
EID: 0037229792
PISSN: 11292369
EISSN: None
Source Type: Journal
DOI: 10.1007/s101940300019 Document Type: Article |
|
Times cited : (1)
|
|
References (2)
|
